Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation–positive non–small-cell lung cancer in a real-world setting (OSI-FACT)

Authors: Sakata, Yoshihiko, Sakata, Shinya, Oya, Yuko, Tamiya, Motohiro, Suzuki, Hidekazu, Shibaki, Ryota, Okada, Asuka, Kobe, Hiroshi, Matsumoto, Hirotaka, Yokoi, Takashi, Sato, Yuki, Uenami, Takeshi, Saito, Go, Tsukita, Yoko, Inaba, Megumi, Ikeda, Hideki, Arai, Daisuke, Maruyama, Hirotaka, Hara, Satoshi, Tsumura, Shinsuke, Morinaga, Jun, Sakagami, Takuro

Source: In European Journal of Cancer December 2021 159:144-153

Real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON)

Authors: Saito, Go, Oya, Yuko, Taniguchi, Yoshihiko, Kawachi, Hayato, Daichi, Fujimoto, Matsumoto, Hirotaka, Iwasawa, Shunichiro, Suzuki, Hidekazu, Niitsu, Takayuki, Miyauchi, Eisaku, Yokoi, Takashi, Yokoyama, Toshihide, Uenami, Takeshi, Sakata, Yoshihiko, Arai, Daisuke, Okada, Asuka, Nagata, Kenji, Teraoka, Shunsuke, Kokubo, Masaki

Source: In Lung Cancer November 2021 161:86-93

EGFR‐mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib

Authors: Hara, Reina, Kanazu, Masaki, Iwai, Ami, Kuge, Tomoki, Ishijima, Mikako, Uenami, Takeshi, Akazawa, Yuki, Yano, Yukihiro, Yamaguchi, Toshihiko, Mori, Masahide

Source: Thoracic cancer. 12(9):1441-1444

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100122991985.0x000001&indx=1&recIds=ETOCvdc_100122991985.0x000001

Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report

Authors: Kuge, Tomoki, Okabe, Fukuko, Yamamoto, Yuji, Ishijima, Mikako, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yano, Yukihiro, Yamaguchi, Toshihiko, Mori, Masahide

Source: Thoracic cancer. 12(12):1935-1939

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100122991886.0x000001&indx=1&recIds=ETOCvdc_100122991886.0x000001

Safety and effectiveness of pirfenidone combined with carboplatin‐based chemotherapy in patients with idiopathic pulmonary fibrosis and non‐small cell lung cancer: A retrospective cohort study

Authors: Yamamoto, Yuji, Yano, Yukihiro, Kuge, Tomoki, Okabe, Fukuko, Ishijima, Mikako, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yamaguchi, Toshihiko, Mori, Masahide

Source: Thoracic cancer. 11(11):3317-3325

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100123860398.0x000001&indx=1&recIds=ETOCvdc_100123860398.0x000001

Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients.

Authors: Iwahori, Kota^1,2 (AUTHOR) iwahori@climm.med.osaka-u.ac.jp, Uenami, Takeshi³ (AUTHOR), Yano, Yukihiro³ (AUTHOR), Ueda, Toshihiko⁴ (AUTHOR), Tone, Mari^1,2 (AUTHOR), Naito, Yujiro² (AUTHOR), Suga, Yasuhiko² (AUTHOR), Fukushima, Kiyoharu² (AUTHOR), Shiroyama, Takayuki² (AUTHOR), Miyake, Kotaro² (AUTHOR), Koyama, Shohei² (AUTHOR), Hirata, Haruhiko² (AUTHOR), Nagatomo, Izumi² (AUTHOR), Kida, Hiroshi⁵ (AUTHOR), Mori, Masahide³ (AUTHOR), Takeda, Yoshito² (AUTHOR), Kumanogoh, Atsushi^2,6,7 (AUTHOR), Wada, Hisashi¹ (AUTHOR)

Source: Scientific Reports. 10/19/2022, Vol. 12 Issue 1, p1-11. 11p.

Subject Terms: *NON-small-cell lung carcinoma, *T cells, *CANCER patients

Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis

Authors: Osa, Akio, Uenami, Takeshi, Naito, Yujiro, Hirata, Haruhiko, Koyama, Shohei, Takimoto, Takayuki, Shiroyama, Takayuki, Futami, Shinji, Nakatsubo, Saeko, Sawa, Nobuhiko, Yano, Yukihiro, Nagatomo, Izumi, Takeda, Yoshito, Mori, Masahide, Kida, Hiroshi, Kumanogoh, Atsushi

Source: Thoracic cancer. 10(11):2183-2187

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100092851697.0x000001&indx=1&recIds=ETOCvdc_100092851697.0x000001

Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)

Authors: Tachihara, Motoko, Negoro, Shunichi, Inoue, Takako, Tamiya, Motohiro, Akazawa, Yuki, Uenami, Takeshi, Urata, Yoshiko, Hattori, Yoshihiro, Hata, Akito, Katakami, Nobuyuki, Yokota, Soichiro

Source: BMC cancer. 18(1):1-6

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184727293.0x000001&indx=1&recIds=ETOCvdc_100184727293.0x000001

Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer

Authors: Koba, Taro, Minami, Seigo, Nishijima-Futami, Yu, Masuhiro, Kentaro, Kimura, Hiromi, Futami, Shinji, Yaga, Moto, Mori, Masahide, Kagawa, Hiroyuki, Uenami, Takeshi, Kohmo, Satoshi, Otsuka, Tomoyuki, Yamamoto, Suguru, Komuta, Kiyoshi, Kijima, Takashi

Source: Cancer chemotherapy and pharmacology. 82(1):111-117

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125396792.0x000001&indx=1&recIds=ETOCvdc_100125396792.0x000001

Bronchial ethanol injection therapy for airway obstruction in lung cancer patients

Authors: Okabe, Fukuko, Yano, Yukihiro, Kuge, Tomoki, Uenami, Takeshi, Kanazu, Masaki, Mori, Masahide

Source: Respirology case reports. 9(9)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100127404311.0x000001&indx=1&recIds=ETOCvdc_100127404311.0x000001

Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer

Authors: Horiike, Atsushi, Takeuchi, Kengo, Uenami, Takeshi, Kawano, Yuko, Tanimoto, Azusa, Kaburaki, Kyohei, Tambo, Yuichi, Kudo, Keita, Yanagitani, Noriko, Ohyanagi, Fumiyoshi, Motoi, Noriko, Ishikawa, Yuichi, Horai, Takeshi, Nishio, Makoto

Source: Lung cancer. 93:43-46

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100038165064.0x000001&indx=1&recIds=ETOCvdc_100038165064.0x000001

A 46-Year-Old Woman With Atelectasis From an Endobronchial Tumor

Authors: Uenami, Takeshi ^*, Kijima, Takashi, Ayata, Masahiro, Hayama, Yoshitomo, Tsuruta, Naotoshi, Saito, Yoshiyuki, Niju, Takashi, Higaki, Naozumi, Ikeda, Toshiyuki

Source: In Chest April 2013 143(4):1170-1173

Safe Treatment of Lung Squamous Cell Carcinoma with Nanoparticle Albumin-Bound Paclitaxel in a Patient with a Previous Hypersensitivity Reaction after Docetaxel Administration

Authors: Uenami, Takeshi

Source: Gan to kagaku ryōhō. 42(3):375-378

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN600703077&indx=1&recIds=ETOCRN600703077

Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report

Authors: Uenami, Takeshi, Hosono, Yuki, Ishijima, Mikako, Kanazu, Masaki, Akazawa, Yuki, Yano, Yukihiro, Mori, Masahide, Yamaguchi, Toshihiko, Yokota, Soichiro

Source: Lung cancer. 109:42-44

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100045841535.0x000001&indx=1&recIds=ETOCvdc_100045841535.0x000001

Classification and regression tree for estimating predictive markers to detect T790M mutations after acquired resistance to first line EGFR-TKI: HOPE-002.

Authors: Tamiya, Motohiro, Fujikawa, Kei, Suzuki, Hidekazu, Yokoyama, Toshihide, Uenami, Takeshi, Tamiya, Akihiro, Sato, Yuki, Saito, Go, Uchida, Junji, Morita, Mitsunori, Hirashima, Tomonori, Fukuda, Yasushi, Kanazu, Masaki, Hosoya, Kazutaka, Suzuki, Takuji, Ueno, Kiyonobu, Fujimoto, Daichi, Kumagai, Toru, Teramukai, Satoshi

Source: Investigational New Drugs; Apr2022, Vol. 40 Issue 2, p361-369, 9p

Subject Terms: LUNG cancer, GENETIC mutation, CONFIDENCE intervals, REGRESSION analysis, PROTEIN-tyrosine kinase inhibitors, AFATINIB, DESCRIPTIVE statistics, TUMOR markers, ODDS ratio, DATA analysis software, DRUG resistance in cancer cells

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.